Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | ATM | Q13315 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CDC25B | P30305 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | SNCA | P37840 | 3/20 | 0.51 |
| ▸ | TTR | P02766 | 1/20 | 0.51 |
| ▸ | FABP4 | P15090 | 1/20 | 0.51 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.51 |
| ▸ | CDK2 | P24941 | 1/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.51 |
| ▸ | CHAT | P28329 | 1/20 | 0.51 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29483445 | 1.00 | ALDH1A1 (0.51) | ALDH1A1HPGDATMTP53CYP3A4 | |
| Ammonia Solution, Strong SCHEMBL9244903 | 0.98 | NR4A1 (0.52) | ALDH1A1HPGDATMTP53CYP3A4 | |
| Ammonia Solution, Strong SCHEMBL9244904 | 0.98 | NR4A1 (0.52) | ALDH1A1HPGDATMTP53CYP3A4 | |
| SCHEMBL7939417 | 0.92 | SNCA (0.48) | ALDH1A1HPGDATMTP53CYP3A4 | |
| SCHEMBL1140668 | 0.89 | SNCA (0.43) | ALDH1A1HPGDATMTP53CYP3A4 | |
| SCHEMBL5051397 | 0.88 | SNCA (0.53) | ALDH1A1CDC25BSNCATTRFABP4 | |
| Iodoacetamide SCHEMBL3286706 | 0.88 | SNCA (0.42) | ALDH1A1HPGDATMTP53CYP3A4 | |
| Questiomycin B SCHEMBL11673657 | 0.88 | ALDH1A1 (0.45) | ALDH1A1HPGDATMTP53CYP3A4 | |
| SCHEMBL28753723 | 0.84 | KEAP1 (0.47) | ALDH1A1HPGDATMTP53CYP3A4 | |
| SCHEMBL8144519 | 0.84 | ALDH1A1 (0.51) | ALDH1A1HPGDATMTP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019079222-A1 | COMPOSITIONS FOR INHIBITING 3' REPAIR EXONUCLEASE 2 AND METHODS OF SCREENING FOR SUCH COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-04-25 | — | — | WO | claimed |
| US-7964363-B2 | Direct determination of vitamin D in serum or plasma | IMMUNDIAGNOSTIK AG (DE) | 2011-06-21 | — | — | US | claimed |
| US-20110104781-A1 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | Life Technologies Corporation (US) | 2011-05-05 | — | — | US | claimed |
| US-20100233782-A1 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | Life Technologies Corporation (US) | 2010-09-16 | — | — | US | claimed |
| EP-2126586-B1 | DIRECT DETERMINATION OF VITAMIN D IN SERUM OR PLASMA | IMMUNDIAGNOSTIK AG (DE) | 2010-06-30 | — | — | EP | claimed |
| US-7718353-B2 | Proteins, sensors, and methods of characterizing analytes using the same | UNIVERSITY OF MARYLAND BALTIMORE COUNTY (US) | 2010-05-18 | — | — | US | claimed |
| US-20100068725-A1 | DIRECT DETERMINATION OF VITAMIN D IN SERUM OR PLASMA | IMMUNDIAGNOSTIK AG (DE) | 2010-03-18 | — | — | US | claimed |
| US-20100034796-A1 | Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction | MEDIGENE AG (DE) | 2010-02-11 | — | — | US | claimed |
| EP-2126586-A1 | DIRECT DETERMINATION OF VITAMIN D IN SERUM OR PLASMA | Immundiagnostik AG (DE) | 2009-12-02 | — | — | EP | claimed |
| EP-2118129-A2 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | Life Technologies Corporation (US) | 2009-11-18 | — | — | EP | claimed |
| US-6872537-B1 | Assays for the detection of microtubule depolymerization inhibitors | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-03-29 | — | — | US | claimed |
| WO-2004101769-A2 | PROTEINS, SENSORS, AND METHODS OF CHARACTERIZING ANALYTES USING THE SAME | UNIVERSITY OF MARYLAND BALTIMORE COUNTY (US) | 2004-11-25 | — | — | WO | claimed |
| EP-1451585-A2 | A NOVEL REAGENTLESS SENSING SYSTEM FOR MEASURING CARBOHYDRATES BASED ON THE GALACTOSE/GLUCOSE BINDING PROTEIN | The University of Kentucky Research Foundation (US) | 2004-09-01 | — | — | EP | claimed |
| US-6699969-B1 | KIT CONTAINING MODULATE MICROTUBULE SEVERING PROTEINS; ACT AS POTENT ANTI-MITOTIC AGENTS; KATANIN; | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-03-02 | — | — | US | claimed |
| US-20030232383-A1 | Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein | DAUNERT SYLVIA (US) | 2003-12-18 | — | — | US | claimed |
| WO-2003060464-A2 | A NOVEL REAGENTLESS SENSING SYSTEM FOR MEASURING CARBOHYDRATES BASED ON THE GALACTOSE/GLUCOSE BINDING PROTEIN | UNIVERSITY OF KENTUCKY (US) | 2003-07-24 | — | — | WO | claimed |
| US-5460944-A | Conjugate of peroxidase and immunologically bindable substance organic buffer and aspartate salt | BOEHRINGER MANNHEIM GMBH (DE) | 1995-10-24 | — | — | US | claimed |
| EP-0415763-A2 | Scanning tunneling microscope utilizing optical fluorescent for reading | HOECHST CELANESE CORPORATION (US) | 1991-03-06 | — | — | EP | claimed |
| EP-0000103-A1 | Purification of glycoproteins and use of glycoproteins to form antiserum compositions | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-12-20 | — | — | EP | claimed |
| US-4049499-A | Microbial medium having fluorescent growth indicator | CORNING GLASS WORKS (US) | 1977-09-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100034796-A1 | Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction | CPT1A, CPT2, CPT1B | ALDH1A1 289/4885HPGD 400/4885ATM 1878/4885 |
| US-20030232383-A1 | Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein | LGALS3BP, GALE, MGAM | ALDH1A1 4622/4885HPGD 4041/4885ATM 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.